Cargando…
Pancancer Analysis of Revealed TDO2 as a Biomarker of Prognosis and Immunotherapy
BACKGROUND: Tryptophan 2,3-dioxygenase (TDO) encoded by TDO2, a rate-limiting enzyme in the kynurenine pathway, catabolizes tryptophan to kynurenine, evades immune surveillance, and promotes tumor growth. Although accumulating evidence suggests a crucial role of TDO2 during tumor formation and devel...
Autores principales: | Cui, Jing, Tian, Yongjie, Liu, Tianhang, Lin, Xueyan, Li, Lanyu, Li, Zhonghui, Shen, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481368/ https://www.ncbi.nlm.nih.gov/pubmed/36118672 http://dx.doi.org/10.1155/2022/5447017 |
Ejemplares similares
-
CCNF is a potential pancancer biomarker and immunotherapy target
por: Wei, Lifang, et al.
Publicado: (2023) -
Pancancer Analysis Revealed the Value of RAC2 in Immunotherapy and Cancer Stem Cell
por: Liu, Ranran, et al.
Publicado: (2023) -
Comprehensive Analysis of the Expressionand Prognosis for TDO2 in Breast Cancer
por: Liu, Qiang, et al.
Publicado: (2020) -
Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors
por: Platten, Michael, et al.
Publicado: (2015) -
Deep learning with multimodal representation for pancancer prognosis prediction
por: Cheerla, Anika, et al.
Publicado: (2019)